R&D

KOR ENG

KOR ENG CHN JPN

All of Medytox starts from R&D.

Medytox R&D Vision and Accomplishments

Medytox concentrates our research capacity on botulinum toxin products as the main pipeline.
Botulinum toxin related culture and separation, refinement technology is a world-recognized, main competitive edge.
Based on this, we are discovering various research technologies such as biofriendly filler development,
toxin testing kit, anti-toxin drug development to become a global biotech company.

R&D Vision

The Best at Botulinum Toxin Industry

The best technology
in botulinum toxin industry

After botulinum toxin researchers started the business in 2000, Korea’s first botulinum toxin medicine, Meditoxin®(trade name: Neuronox®, Siax® etc.) was approved by KFDA and launched in the market in 2006. Furthermore, Medytox developed a next-generation botulinum toxin pharmaceutical distinguished in its safety, efficacy, and stability. When the next generation botulinum toxin enters the advanced markets such as the US and Europe, Medytox will go beyond Korea’s best botulinum toxin pharmaceutical corporation to become the world leader.

The Best at Medical Aesthetics

The best technology
in aesthetic plastic
surgery industry

After succeeding in developing botulinum toxin pharmaceuticals, Medytox developed a dermal filler, one of the major products in the aesthetic market. We succeeded in developing a filler using most biofriendly material hyaluronic acid and developed the manufacturing process and the analytical method and built GMP compliant facility for production. Medytox successfully secured the botulinum toxin and the filler in global medical aesthetic industry to become the best company in the global aesthetic industry.

Global Biotech Company

Medytox has been working towards the vision of growing as a global biotech company. By utilizing infrastructure and biopharmaceutical development capacity built from botulinum toxin pharmaceutical development, we generate profit and reinvest it in developing innovative biopharmaceuticals. With the goal of success in developing new bio pharmaceuticals in the near future,we are cooperating with external R&D partners.

Medytox is continually growing as a global biotech company through continuous product development and investment.